.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Modern pharmacology faces high costs and long development cycles. Consequently, researchers are turning to a drug repositioning web server like DRHIN to find new uses for approved medications. This integrated platform utilizes deep learning to analyze complex biological networks. Specifically, it combines transcriptomics, proteomics, and microbiome data into heterogeneous information networks. By doing so, it clarifies the molecular mechanisms that drive drug effectiveness across different diseases.
DRHIN stands out because it incorporates 19 state-of-the-art graph representation algorithms. These tools allow scientists to compare and evaluate network data with high precision. Furthermore, the platform offers a code-free portal. This accessibility enables clinicians to perform predictive tasks without needing deep programming knowledge. In addition, high-performance computing ensures that the system processes million-scale networks quickly. Clinicians can use these insights to repurpose existing drugs for new indications or identify potential therapies for specific diseases.
Repurposing existing drugs reduces the safety risks associated with new chemical entities. Moreover, it significantly lowers the financial burden of drug development. Therefore, tools like DRHIN empower the global medical community to deliver safer treatments faster. Similarly, the platform makes analyses reproducible and accessible for researchers worldwide. In conclusion, DRHIN provides a robust framework for identifying potential therapies in real-world scenarios.
DRHIN acts as a specialized drug repositioning web server that analyzes biological data to find new therapeutic indications for existing, approved drugs.
The platform integrates transcriptomics, proteomics, and microbiome data across eight biological entities and 19 association types to build comprehensive networks.
No, DRHIN provides a code-free portal, making complex deep learning analyses accessible to medical professionals and researchers without programming expertise.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
DRHIN uses deep learning and heterogeneous information networks to repurpose existing drugs, offering a cost-effective path for new disease treatments....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
